Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Miraca Holdings Inc

+ Add to Watchlist

MRCHF:US

48.0000 USD 6.8000 16.50%

As of 21:10:01 ET on 02/23/2015.

Snapshot for Miraca Holdings Inc (MRCHF)

Open: 48.0000 Day's Range: 48.0000 - 48.0000 Volume: 100
Previous Close: 41.2000 52wk Range: 41.2000 - 48.0000 1-Yr Rtn: -

Stock Chart for MRCHF

No chart data available.
  • MRCHF:US 48.0000
  • 1D
  • 1M
  • 1Y
41.2000
Interactive MRCHF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRCHF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 20.7393
Relative P/E vs. SPX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 275.7900
Est. PEG Ratio 3.0954
Market Cap (M USD) 2,833.85
Shares Outstanding (M) 59.04
30 Day Average Volume 3
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.68%
Cash Dividend (JPY) 46.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 4.17%
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRCHF

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for MRCHF

Miraca Holdings Inc. develops, manufactures, exports, and imports clinical reagents, medical drugs, and medical equipment. The Company's clinical reagents are for cancer, malignant tumor, hypothyroidism, diabetes, and infectious diseases including AIDS. Miraca Holdings also conducts clinical tests for hospitals and medical organizations.

Hiromasa SuzukiPresidentShinji OgawaSenior Executive Officer
Hiromitsu TazawaSenior Executive OfficerTakeshi KoyamaManaging Executive Officer
More Company Profile & Key Executives for MRCHF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil